Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9790299 | 0.84 | GAA (0.32) | GAA | |
| SCHEMBL320170 | 0.79 | ALDH1A1 (0.37) | — | |
| SCHEMBL701397 | 0.79 | GAA (0.38) | GAA | |
| SCHEMBL10723502 | 0.77 | — | — | |
| SCHEMBL29791684 | 0.77 | GAA (0.42) | GAA | |
| SCHEMBL701399 | 0.76 | GAA (0.39) | GAA | |
| SCHEMBL18250840 | 0.74 | GAA (0.43) | GAA | |
| SCHEMBL42442 | 0.72 | ALDH1A1 (0.34) | — | |
| SCHEMBL1311682 | 0.72 | GAA (0.39) | GAA | |
| SCHEMBL14488752 | 0.71 | GAA (0.40) | GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1303258-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | AstraZeneca AB (SE) | 2003-04-23 | — | — | EP | claimed |
| WO-2002003958-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | ASTRAZENECA AB (SE) | 2002-01-17 | — | — | WO | claimed |
| US-12620622-B2 | Compound including sulfur-containing heterocyclic cation and bis(oxolato)borate anion, electrolytic solution and electrochemical device including the same | DAIKIN INDUSTRIES, LTD. (JP) | 2026-05-05 | — | — | US | disclosed |
| US-20250260063-A1 | ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, SECONDARY BATTERY, AND LITHIUM-ION SECONDARY BATTERY | DAIKIN INDUSTRIES, LTD. (JP) | 2025-08-14 | — | — | US | disclosed |
| US-20250174720-A1 | ELECTROLYTE, ELECTROCHEMICAL DEVICE, LITHIUM ION SECONDARY BATTERY, AND MODULE | DAIKIN INDUSTRIES, LTD. (JP) | 2025-05-29 | — | — | US | disclosed |
| US-12315885-B2 | Electrolytic solution, electrochemical device, lithium-ion secondary battery, and module | DAIKIN INDUSTRIES, LTD. (JP) | 2025-05-27 | — | — | US | disclosed |
| EP-4553940-A1 | SECONDARY BATTERY | DAIKIN INDUSTRIES, LTD. (JP) | 2025-05-14 | — | — | EP | disclosed |
| US-20250132344-A1 | SURFACE TREATMENT AGENT FOR ELECTRODE MATERIAL, POSITIVE ELECTRODE ACTIVE MATERIAL, CURRENT COLLECTOR FOIL, NEGATIVE ELECTRODE ACTIVE MATERIAL, CONDUCTIVE AID, ELECTRODE, BATTERY, METHOD FOR MANUFACTURING POSITIVE ELECTRODE ACTIVE MATERIAL, METHOD FOR MANUFACTURING CURRENT COLLECTOR FOIL, METHOD FOR MANUFACTURING NEGATIVE ELECTRODE ACTIVE MATERIAL, METHOD FOR MANUFACTURING CONDUCTIVE AID, AND METHOD FOR MANUFACTURING ELECTRODE | DAIKIN INDUSTRIES, LTD. (JP) | 2025-04-24 | — | — | US | disclosed |
| US-12278336-B2 | Alkali metal electrode treatment agent, electrolytic solution for alkali metal secondary battery, alkali metal electrode, alkali metal secondary battery, and module | DAIKIN INDUSTRIES, LTD. (JP) | 2025-04-15 | — | — | US | disclosed |
| US-20250096327-A1 | ELECTROLYTIC SOLUTION AND SECONDARY BATTERY USING SAME | DAIKIN INDUSTRIES, LTD. (JP) | 2025-03-20 | — | — | US | disclosed |
| US-12249689-B2 | Electrolyte solution, electrochemical device, lithium ion secondary battery, and module | DAIKIN INDUSTRIES, LTD. (JP) | 2025-03-11 | — | — | US | disclosed |
| WO-2015200657-A1 | COPOLYMERS INCLUDING A TRIAZINE GROUP AND COMPOSITIONS INCLUDING THEM | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2015-12-30 | — | — | WO | disclosed |
| US-20150353662-A1 | COPOLYMERS INCLUDING ULTRAVIOLET ABSORBING GROUPS AND FLUOROPOLYMER COMPOSITIONS INCLUDING THEM | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2015-12-10 | — | — | US | disclosed |
| US-20150337096-A1 | FLUOROPOLYMER COMPOSITION INCLUDING AN OLIGOMER HAVING AN ULTRAVIOLET ABSORBING GROUP | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2015-11-26 | — | — | US | disclosed |
| EP-2935373-A1 | COPOLYMERS INCLUDING ULTRAVIOLET ABSORBING GROUPS AND FLUOROPOLYMER COMPOSITIONS INCLUDING THEM | 3M Innovative Properties Company (US) | 2015-10-28 | — | — | EP | disclosed |
| EP-2935472-A1 | FLUOROPOLYMER COMPOSITION INCLUDING AN OLIGOMER HAVING AN ULTRAVIOLET ABSORBING GROUP | 3M Innovative Properties Company (US) | 2015-10-28 | — | — | EP | disclosed |
| WO-2014100551-A1 | COPOLYMERS INCLUDING ULTRAVIOLET ABSORBING GROUPS AND FLUOROPOLYMER COMPOSITIONS INCLUDING THEM | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2014-06-26 | — | — | WO | disclosed |
| WO-2014100580-A1 | FLUOROPOLYMER COMPOSITION INCLUDING AN OLIGOMER HAVING AN ULTRAVIOLET ABSORBING GROUP | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2014-06-26 | — | — | WO | disclosed |
| EP-1303258-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | AstraZeneca AB (SE) | 2003-04-23 | — | — | EP | disclosed |
| WO-2002003958-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | ASTRAZENECA AB (SE) | 2002-01-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250174720-A1 | ELECTROLYTE, ELECTROCHEMICAL DEVICE, LITHIUM ION SECONDARY BATTERY, AND MODULE | HCN2, HCN1, HCN3 | GAA 3690/4885 |
| US-12620622-B2 | Compound including sulfur-containing heterocyclic cation and bis(oxolato)borate anion, electrolytic solution and electrochemical device including the same | ASH2L, OLA1, ODC1 | GAA 3344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.